Expertise: Oncology & Hematology 105 results
Are You Engaging a CRO at the Right Point in Your Drug Development Program?
The traditional entry point for clinical research organization (CRO) engagement is delivery of the first clinical research study. However, companies with limited internal resources may benefit from engaging with a CRO as early as possible to leverage the full breadth...
Sandy Shah, M.D.
Adaptive Trial Designs in Early Oncology: Minimizing Risk & Accelerating Timelines
Over the past decade, significant advances have improved our understanding of the genetic and molecular mechanisms that lead to cancer.
Celebrating World Cancer Day: An Interview with Leading Oncology Experts
Every year on February 4th, the world comes together to recognize World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC). This day unites individuals, communities, and organizations in the fight against cancer while raising...
Building Your Oncology NDA Playbook: Key Insights for the Journey to Approval
Bringing an Oncology Asset to Market: In-House vs Outsource?
During the multifaceted journey of bringing a promising therapeutic to market, sponsors are faced with a critical choice—whether to manage asset development in-house or to outsource to a clinical research organization (CRO) partner. This decision can influence timelines, costs, control...